| abstract |
The invention relates to compounds of the general formula (I), wherein R1-R5 and R2’-R4’ are as described in the claims and to pharmaceutically suitable acid additon salts, optical pure enantiomers, racemates or diastereomeric mixtures thereof for the treatment of Alzheimer’s disease or common cancers. |